Navigation Links
Alexza Provides Pipeline Update
Date:7/31/2014

s and uncertainties, particularly those inherent in the process of developing and commercializing drugs, including the ability of Alexza and our partners, Teva and Ferrer, to effectively and profitably commercialize ADASUVE, estimated product revenues and royalties associated with the sale of ADASUVE, the adequacy of the Company's capital to support the Company's operations, and the Company's ability to raise additional funds and the potential terms of such potential financings, whether the Company's financial resources will be sufficient to meet the its business objectives and operational requirements to manufacture ADASUVE and to develop AZ-002, AZ-008 and AZ-009, results of studies and trials may not be predictive of the future clinical trial results of AZ-002, AZ-008, AZ-009 or other product candidates, the protection and market exclusivity provided by the Company's intellectual property for its product candidates, including rights to AZ-002, AZ-008, AZ-009 and the Staccato platform and the impact of competitive products and technological changes. The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements. These and other risks concerning Alexza's business are described in additional detail in the Company's Annual Report on Form 10-K for the year ended December 31, 2013 and the Company's other Periodic and Current Reports filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

Logo - http://photos.prnewswire.com/prnh/20140121/SF49110LOGO


'/>"/>
SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
2. Alexza Receives Complete Response Letter for Adasuve™ NDA
3. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexza Pharmaceuticals Inc.
4. Alexza Announces Reverse Stock Split in Order to Maintain NASDAQ Listing
5. Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
6. Alexza Announces Management Promotions
7. Alexza Reports 2012 Second Quarter Financial Results and Provides Business Update
8. Alexza Pharmaceuticals to Present at the Stifel Nicolaus 2012 Healthcare Conference
9. Alexza Pharmaceuticals Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
10. Alexza to Report 2012 Year-End Financial Results on Tuesday, March 26, 2013
11. Peter W. Schineller Joins Alexza Pharmaceuticals as Senior Vice President and Chief Commercial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... RALEIGH, N.C. , Dec. 23, 2014  Endo ... ENDP ) (TSX: ENL), and BioDelivery Sciences ... that they have submitted a New Drug Application (NDA) ... and Drug Administration (FDA).  Buprenorphine HCl Buccal Film is ... to require daily, around-the-clock, long-term opioid treatment and for ...
(Date:12/22/2014)... LAWRENCE, Mass. , Dec. 22, 2014 /PRNewswire/ ... a leading manufacturer of innovative dialysis products, announced ... (FDA) has cleared its System One™ to perform ... sleeping, known as home nocturnal hemodialysis. NxStage,s® System ... cleared by the FDA for this indication. ...
(Date:12/22/2014)... 2014   TRU-D SmartUVC LLC, producers of ... announced today that the General Services Administration has awarded ...   This newly formed agreement will allow ... government purchasers, including Department of Veteran Affairs and Department ... contacts purchasing solutions for the Ebola effort in ...
Breaking Medicine Technology:Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2
... , Study Discussed at the American Podiatric Medical ... Md., July 30 Foot complications, such as open wounds and ulcers, ... treat. However, a new wound dressing powder, which acts very much ... and reduce the amount of pain that a patient suffering from a ...
... , PHILADELPHIA, July 29 Pediatric researchers ... the development of type 2 diabetes also predisposes children to having ... genetic influence on how prenatal events may set the stage for ... Researchers from The Children,s Hospital of Philadelphia and the University ...
Cached Medicine Technology:New Powder Speeds Healing of Difficult Foot Wounds 2Diabetes Gene Raises Odds of Lower Birth Weight 2Diabetes Gene Raises Odds of Lower Birth Weight 3
(Date:12/26/2014)... CA (PRWEB) December 26, 2014 ... score of 3.1 out of 5. This score reflects ... low level of product specialization, low switching costs and ... is reduced by the low availability of substitutes for ... world price of steel and aluminum, key inputs in ...
(Date:12/26/2014)... 2014 India Network Foundation, a non-profit ... USA, announced today a new version of “ EasySelect ... the right plan for their visiting parents. The technology ... the selection process when choosing an insurance plan by ... only a few clicks. Many elderly Asian Indian parents ...
(Date:12/25/2014)... 2014 This is a professional and ... Sterilizers industry with a focus on the Chinese market. ... of the Sterilizers manufacturers and is a valuable source ... in the industry. This report provides a basic overview ... technology. In this part, the report presents the company ...
(Date:12/25/2014)... three months the trends for evening dresses shift ... one of the hottest styles in the next few months.” ... releases 26 A-line sweetheart evening dresses, and announces the availability ... are trying our best to help a lady to show ... affordable prices, we provide discounted delivery costs to our customers ...
(Date:12/25/2014)... 25, 2014 BambooFlooringChina.com sells many bamboo ... bamboo flooring. Today, the company announces big discounts ... styles and colors. , BambooFlooringChina.com is the world’s leader ... promotion is valid until Jan. 20, 2015. , The ... woven with a natural thread. All the bamboo strips ...
Breaking Medicine News(10 mins):Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
... (BUSM) and Boston Medical Center (BMC), in collaboration with other ... months premature, are at three times the risk for screening ... Children who screen positive on M-CHAT may be at ... the January issue of Journal of Pediatrics . , ...
... dying from "super bugs" because our antibiotic arsenal has run ... bacteria, warn infectious disease researchers at The University of Texas ... in The New England Journal of Medicine , Barbara ... past, present and future response to preventing and treating "super ...
... 27 the Service Employees International Union ... UHW-W) for three separate reasons: 1. Serious financial wrongdoing ... Secretary of Labor Ray Marshall in his trusteeship ... cooperate with the Union,s democratic decision on the jurisdiction of ...
... two years; lawmakers demand criminal probe after U.S. health ... in 2007 and 2008. , , WEDNESDAY, Jan. 28 (HealthDay ... recall late Wednesday for all peanut products made over ... in the current salmonella outbreak. , The recall was ...
... Company well positioned for 2009 and beyondCompany records $2.7 billion ... (NYSE: BSX ) today announced financial results for ... as well as guidance for net sales and earnings per ... Fourth quarter highlights: , , ...
... CAMBRIDGE, Mass. Modifying the environment by using everything ... as important as mosquito nets and vaccinations in the ... MIT researchers. , The researchers have developed a new ... control the spread of malaria, one of the world,s ...
Cached Medicine News:Health News:Study finds preemies more likely to score positive 2Health News:Call to action: Running out of options to fight ever-changing 'super bugs' 2Health News:Call to action: Running out of options to fight ever-changing 'super bugs' 3Health News:Statement by UHW Trustee Eliseo Medina on the Trusteeship of Local UHW-W 2Health News:Statement by UHW Trustee Eliseo Medina on the Trusteeship of Local UHW-W 3Health News:Statement by UHW Trustee Eliseo Medina on the Trusteeship of Local UHW-W 4Health News:All Products at Georgia Peanut Plant Recalled 2Health News:All Products at Georgia Peanut Plant Recalled 3Health News:All Products at Georgia Peanut Plant Recalled 4Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 2Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 3Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 4Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 5Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 6Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 7Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 8Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 9Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 10Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 11Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 12Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 13Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 14Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 15Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 16Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 17Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 18Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 19Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 20Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 21Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 22Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 23Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 24Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 25Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 26Health News:Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 27